Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome
А. D. Makatsariya(Sechenov University), D. V. Mitryuk(Nicolae Testemițanu State University of Medicine and Pharmacy), Д. В. Блинов(Institute of Social and Preventive Medicine), А. С. Шкода(City Clinical Hospital), V. B. Nemirovskiy(City Clinical Hospital), К. N. Grigoreva(Sechenov University), J. Kh. Khizroeva(Sechenov University), В. О. Бицадзе(University of Rome Tor Vergata), Ismaı̈l Elalamy, M. V. Tretyakova(Sechenov University), М. A. Мингалимов(Sechenov University)
Cited by 31
Related Papers
Editor's Choice – European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis
|European Journal of Vascular and Endovascular Surgery|2020|709
Role of Doppler ultrasound at time of diagnosis of late‐onset fetal growth restriction in predicting adverse perinatal outcome: prospective cohort study
|Ultrasound in Obstetrics and Gynecology|2019|115
Infertility in women with systemic autoimmune diseases
|Best Practice & Research Clinical Endocrinology & Metabolism|2019|113
HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome
|Autoimmunity Reviews|2018|76
Catastrophic Antiphospholipid Syndrome
|International Journal of Molecular Sciences|2024|54